Skip to content
10-K/A

Annual Report

NASCENT BIOTECH, INC.

0001477932-23-004986

← back to feed
Filed
Jul 3, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 29, 2023 141.4M sh
Operating Cash Flow FY 2023 · Mar 31, 2023 −$1.79M
Operating Cash Flow FY 2023 · Mar 31, 2022 $413.48K
Stockholders Equity FY 2023 · Mar 31, 2023 −$1.3M
Stockholders Equity FY 2023 · Mar 31, 2022 −$671.48K
Stockholders Equity FY 2023 · Mar 31, 2021 −$472.51K
Current Liabilities FY 2023 · Mar 31, 2023 $1.55M
Current Liabilities FY 2023 · Mar 31, 2022 $776.89K
Total Liabilities FY 2023 · Mar 31, 2023 $1.55M
Total Liabilities FY 2023 · Mar 31, 2022 $776.89K
Current Assets FY 2023 · Mar 31, 2023 $255K
Current Assets FY 2023 · Mar 31, 2022 $105.41K
Total Assets FY 2023 · Mar 31, 2023 $255K
Total Assets FY 2023 · Mar 31, 2022 $105.41K
Rd Expense FY 2023 · Mar 31, 2023 $270.53K
Rd Expense FY 2023 · Mar 31, 2022 $197.41K
Net Income FY 2023 · Mar 31, 2023 −$2.8M
Net Income FY 2023 · Mar 31, 2022 −$470.39K
Operating Income FY 2023 · Mar 31, 2023 −$2.16M
Operating Income FY 2023 · Mar 31, 2022 −$457.05K
Revenue FY 2023 · Mar 31, 2023 $0
Revenue FY 2023 · Mar 31, 2022 $1M